Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2023

Nov 3, 2023

30718_dirs_2023-11-03_0046428a-69b7-4169-85d1-56b3c126fe66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-11-01

Reporting Person: Geist William (PRESIDENT, PROTEIN SCIENCES)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-01 Restricted Stock Units $ A 19857 Acquired Common Stock (19857) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9960 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Common Stock (3360) 3360 Direct
Stock Options (Right to Buy) $100.39 2029-02-01 Common Stock (11936) 11936 Direct
Stock Options (Right to Buy) $100.39 2029-02-01 Common Stock (15912) 15912 Direct
Restricted Stock Units $ Common Stock (7140) 7140 Direct
Stock Options (Right to Buy) $94.52 2029-08-15 Common Stock (22200) 22200 Direct
Stock Options (Right to Buy) $94.52 2029-08-15 Common Stock (29600) 29600 Direct
Restricted Stock Units $ Common Stock (8377) 8377 Direct
Stock Options (Right to Buy) $84.61 2030-08-15 Common Stock (22544) 22544 Direct
Stock Options (Right to Buy) $84.61 2030-08-15 Common Stock (30059) 30059 Direct

Footnotes

F1: Includes 6,640 shares of restricted stock for which the risk of forfeiture will lapse as to 3,320 shares on each of 2/1/2024 and 2/1/2025.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F3: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F4: Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026.

F5: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

F7: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F8: Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.

F9: 9,929 restricted stock units vest on 11/1/2024 and 9,928 restricted stock units vest on 11/1/2025.